Suppr超能文献

核磁共振揭示了NS5A蛋白的内在无序结构域2作为丙型肝炎病毒RNA聚合酶NS5B的变构调节剂。

NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.

作者信息

Bessa Luiza M, Launay Hélène, Dujardin Marie, Cantrelle François-Xavier, Lippens Guy, Landrieu Isabelle, Schneider Robert, Hanoulle Xavier

机构信息

From the University of Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France.

From the University of Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000 Lille, France

出版信息

J Biol Chem. 2017 Nov 3;292(44):18024-18043. doi: 10.1074/jbc.M117.813766. Epub 2017 Sep 14.

Abstract

Non-structural protein 5B (NS5B) is the RNA-dependent RNA polymerase that catalyzes replication of the hepatitis C virus (HCV) RNA genome and therefore is central for its life cycle. NS5B interacts with the intrinsically disordered domain 2 of NS5A (NS5A-D2), another essential multifunctional HCV protein that is required for RNA replication. As a result, these two proteins represent important targets for anti-HCV chemotherapies. Despite this importance and the existence of NS5B crystal structures, our understanding of the conformational and dynamic behavior of NS5B in solution and its relationship with NS5A-D2 remains incomplete. To address these points, we report the first detailed NMR spectroscopic study of HCV NS5B lacking its membrane anchor (NS5B). Analysis of constructs with selective isotope labeling of the δ1 methyl groups of isoleucine side chains demonstrates that, in solution, NS5B is highly dynamic but predominantly adopts a closed conformation. The addition of NS5A-D2 leads to spectral changes indicative of binding to both allosteric thumb sites I and II of NS5B and induces long-range perturbations that affect the RNA-binding properties of the polymerase. We compared these modifications with the short- and long-range effects triggered in NS5B upon binding of filibuvir, an allosteric inhibitor. We demonstrate that filibuvir-bound NS5B is strongly impaired in the binding of both NS5A-D2 and RNA. NS5A-D2 induces conformational and functional perturbations in NS5B similar to those triggered by filibuvir. Thus, our work highlights NS5A-D2 as an allosteric regulator of the HCV polymerase and provides new insight into the dynamics of NS5B in solution.

摘要

非结构蛋白5B(NS5B)是一种依赖RNA的RNA聚合酶,可催化丙型肝炎病毒(HCV)RNA基因组的复制,因此对其生命周期至关重要。NS5B与NS5A的内在无序结构域2(NS5A-D2)相互作用,NS5A是另一种对RNA复制必不可少的多功能HCV蛋白。因此,这两种蛋白是抗HCV化疗的重要靶点。尽管具有这种重要性且存在NS5B晶体结构,但我们对NS5B在溶液中的构象和动态行为及其与NS5A-D2的关系仍不完全了解。为了解决这些问题,我们报告了对缺乏膜锚定的HCV NS5B(NS5B)的首次详细核磁共振光谱研究。对异亮氨酸侧链δ1甲基进行选择性同位素标记的构建体分析表明,在溶液中,NS5B具有高度动态性,但主要采用封闭构象。添加NS5A-D2会导致光谱变化,表明其与NS5B的变构拇指位点I和II均结合,并诱导影响聚合酶RNA结合特性的远程扰动。我们将这些修饰与在NS5B中由变构抑制剂菲布韦(filibuvir)结合引发的短程和远程效应进行了比较。我们证明,与菲布韦结合的NS5B在结合NS5A-D2和RNA方面均受到严重损害。NS5A-D2在NS5B中诱导的构象和功能扰动类似于由菲布韦引发的扰动。因此,我们的工作突出了NS5A-D2作为HCV聚合酶的变构调节剂,并为NS5B在溶液中的动力学提供了新的见解。

相似文献

1
NMR reveals the intrinsically disordered domain 2 of NS5A protein as an allosteric regulator of the hepatitis C virus RNA polymerase NS5B.
J Biol Chem. 2017 Nov 3;292(44):18024-18043. doi: 10.1074/jbc.M117.813766. Epub 2017 Sep 14.
3
Ligand-induced changes in hepatitis C virus NS5B polymerase structure.
Antiviral Res. 2010 Nov;88(2):197-206. doi: 10.1016/j.antiviral.2010.08.014. Epub 2010 Sep 9.
5
A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication.
J Biol Chem. 2015 Jul 31;290(31):19104-20. doi: 10.1074/jbc.M115.644419. Epub 2015 Jun 17.
6
Biochemical study of the comparative inhibition of hepatitis C virus RNA polymerase by VX-222 and filibuvir.
Antimicrob Agents Chemother. 2012 Feb;56(2):830-7. doi: 10.1128/AAC.05438-11. Epub 2011 Dec 5.
7
Thumb inhibitor binding eliminates functionally important dynamics in the hepatitis C virus RNA polymerase.
Proteins. 2013 Jan;81(1):40-52. doi: 10.1002/prot.24154. Epub 2012 Sep 15.
10
Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A.
J Biol Chem. 2012 Dec 28;287(53):44249-60. doi: 10.1074/jbc.M112.392209. Epub 2012 Nov 14.

引用本文的文献

1
2
NMR Spectroscopy of supramolecular chemistry on protein surfaces.
Beilstein J Org Chem. 2020 Oct 9;16:2505-2522. doi: 10.3762/bjoc.16.203. eCollection 2020.
3
New technologies to analyse protein function: an intrinsic disorder perspective.
F1000Res. 2020 Feb 10;9. doi: 10.12688/f1000research.20867.1. eCollection 2020.
5
Interaction study between HCV NS5A-D2 and NS5B using F NMR.
J Biomol NMR. 2018 Jan;70(1):67-76. doi: 10.1007/s10858-017-0159-9. Epub 2017 Dec 7.

本文引用的文献

1
The discovery of a pan-genotypic, primer grip inhibitor of HCV NS5B polymerase.
Medchemcomm. 2017 Feb 8;8(4):796-806. doi: 10.1039/c6md00636a. eCollection 2017 Apr 1.
2
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med. 2017 Jun 1;376(22):2134-2146. doi: 10.1056/NEJMoa1613512.
4
Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.
ACS Infect Dis. 2016 Nov 11;2(11):839-851. doi: 10.1021/acsinfecdis.6b00143. Epub 2016 Oct 5.
5
Reconstitution and Functional Analysis of a Full-Length Hepatitis C Virus NS5B Polymerase on a Supported Lipid Bilayer.
ACS Cent Sci. 2016 Jul 27;2(7):456-66. doi: 10.1021/acscentsci.6b00112. Epub 2016 Jun 13.
6
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
7
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.
Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):338-51. doi: 10.1038/nrgastro.2016.60. Epub 2016 May 5.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验